Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

GSK hopes real-world data flu app will go viral

Flumji has been developed by MIT Connection Science

GSK GlaxoSmithKline MIT Connection Science Flumoji mobile Android app 

GlaxoSmithKline is sponsoring a new Android mobile app aims to raise awareness, educate users and collect health outcomes data.

Flumoji was developed by MIT Connection Science, a cross-discipline group from the US Institute, and is being positioned as a 'health wizard'.

“Tell it how you feel and it will magically learn how to help protect you from flu and other ailments,” as MIT's description of the app puts it.

Detailed information on how user data will be collected and put to work is not apparent and this lack of transparency, along with the app's multiple purposes, could hold it back.

Nevertheless, GSK hopes Flumoji will 'go viral', as users share the free app online and watch it spread to friends and friends-of-friends, something they can then keep track of a 'Flumoji Spreaders' leaderboard.

Hopefully the app will prove more shareable than the firm's #Flumoji hashtag, which has been used just six times on Twitter to date, with five tweets from GSK and one from an industry observer.

17th January 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....

Infographics